Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies

Glioblastoma multiforme is the most common and aggressive primary brain tumor. Even with aggressive treatment including surgical resection, radiation, and chemotherapy, patient outcomes remain poor, with five-year survival rates at only 10%. Barriers to treatment include inefficient drug delivery ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Caffery, Breanne, Lee, Jeoung Soo, Alexander-Bryant, Angela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359729/
https://www.ncbi.nlm.nih.gov/pubmed/30654536
http://dx.doi.org/10.3390/nano9010105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359729/
https://www.ncbi.nlm.nih.gov/pubmed/30654536
http://dx.doi.org/10.3390/nano9010105

Ejemplares similares